For Brian Meissner, the sore throat and fever he experienced in January when he became infected with COVID-19 were harbingers of a host of health issues to come.
Meissner, a 36-year-old resident of Chiba Prefecture, says he had received two COVID vaccine shots and was waiting for a third when he fell ill. After going to a local drive-in clinic and testing positive for the coronavirus, he was prescribed molnupiravir, an oral medication approved for COVID treatment, and was told to rest at home for two weeks.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
KEYWORDS
